Month: July 2023

CNH Industrial is committed to building a sustainable future – both through the design and development of their products and the plants where they build them. They have set an emissions target to have a 90% share of renewable electricity at these sites by 2030.

“We are proud to be using recycled energy,” declares Amit Kumar Tiwari, Electrical Lead at the CASE Construction Equipment manufacturing plant in Pithampur, India. His enthusiasm about the ecofriendly developments at their operations in India can be seen in a new film at

Through interviews with employees and the Head of Energy, they showcase how the solar panel installations at their sites are helping to attain CNH’s renewable energy goals.

And the data is impressive: a reduction of around 26,000 tons of CO2 emissions over 10 years at our Greater Noida, India plant, while the Pithampur, India manufacturing facility gets 20% of its energy from solar power.

To read more about CNH Industrial’s photovoltaic projects around the world and specifically in Pithampur, check out the latest story in our ‘A Sustainable Year’ online magazine at: .

Company reduces GHG emissions by 27% since 2018, equivalent to the emissions nearly 60,000 gasoline-fueled cars generate in a yearReports 71% of 2022 net sales are from sustainable solutionsInvests $900 million in research and development for sustainable solutions since 2020Achieves 75% of waste target and accelerates water target progress 

Intelligent power management company Eaton (NYSE:ETN) released its 2022 Sustainability Report. The report features the company’s substantial progress toward its 2030 sustainability goals.

Eaton’s 2022 report showcases more transparency and reporting rigor than ever before, including the company’s forward-thinking approach to climate-related risks and opportunities, through its Task Force on Climate-related Financial Disclosures (TCFD) section, embedded directly into the report.

The report shows that Eaton is ahead or on pace to meet several of its targets, including:

Carbon emissions: Reduced GHG emissions by 27% in its operations since 2018 through increased energy efficiency, energy conservation, and shifts to renewable energy.Sustainable solutions: Solutions that enable electrification, energy transition, electric grid resilience, increase efficiency in ground and air transportation or improve air quality represented 71% of the company’s net sales in 2022, up from 65% in 2021.Sustainable investments: Invested $900 million in research and development for sustainable solutions since 2020, up from $528 million in 2021.Water: Certified 8% of manufacturing sites as zero water discharge, focusing on sites in water-stressed areas.Waste: Certified 75% of manufacturing sites as zero waste to landfill, moving the company closer to its goal to certify 100% by 2030.Employee development: Met company employee training hours goal.

Full results can be seen on the company’s 2022 Sustainability Dashboard.

“At Eaton, we embrace the tremendous responsibility we have to act now to address climate change,” said Craig Arnold, chairman and chief executive officer, Eaton. “We continue to push forward in our journey to pursue our bold environmental, social and governance goals—and we’re making significant progress.”

“Our 2022 Sustainability Report describes in more detail than ever how we’re helping the world decarbonize electricity and optimize energy usage,” said Harold Jones, chief sustainability officer and executive vice president, Eaton Business System, Eaton. “It’s critical we keep our momentum strong to reach our targets and make good on our mission to improve the quality of life and the environment.”

Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, operate sustainably, and help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and society.

Founded in 1911, Eaton is marking its 100th anniversary of being listed on the New York Stock Exchange. We reported revenues of $20.8 billion in 2022 and serve customers in more than 170 countries. For more information, visit www.eaton.com. Follow us on Twitter and LinkedIn.

Originally published on Built From Scratch

Shawn is a Rapid Deployment Center associate who works to quickly receive and sort inbound freight for Home Depot stores and fulfillment centers. When Shawn’s daughter was born preterm with congenital heart defects, a two-month stay in the neonatal intensive care unit (NICU) caused his family to fall behind with rent and utility bill payments.

Here’s how The Homer Fund helped him catch up on past due living expenses.

Since 1999, The Homer Fund has granted nearly $255 million to more than 178,000 associates in need, thanks to the collective support from fellow Home Depot associates. To learn about donation options, check eligibility or apply for a grant, visit THDHomerFund.org.

Keep up with all the latest Home Depot news! Subscribe to our bi-weekly news update and get the top Built from Scratch stories delivered straight to your inbox.

Originally published by Walgreens Boots Alliance

DEERFIELD, Ill. and SAN FRANCISCO, July 13, 2023 /3BL/ – Walgreens and Freenome announced a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. 

“At Walgreens, our aim is to help every community we serve see clinical research as a viable care option,” said Ramita Tandon, chief clinical trials officer, Walgreens. “Through our nationwide presence and trusted pharmacists, we can reach and engage previously underserved patient populations for clinical trials. Supporting the identification of cancers when they are most treatable is one more way we are helping to improve health outcomes of our communities and patients while advancing research in oncology.” 

Working together with technology provider Curebase, Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to evaluate blood-based early detection tests for multiple cancers. Using Curebase’s platform, Walgreens will deliver targeted outreach to potentially eligible patients and caregivers of all backgrounds via text, email or in-person consultation at the pharmacy. After completing a pre-screen, eligible patients are invited to enroll in the study. Walgreens healthcare providers will then perform a single blood draw at one of the company’s clinical trial locations and conduct a telehealth patient follow-up one year after their participation. 

“Freenome’s goal is to make early cancer screening more convenient for everyone, and our clinical research should reflect that availability and accessibility. With community reach, study conduct capabilities, national presence and real-world data generation resources, Walgreens is a natural partner to help deliver on that goal,” said Lance Baldo, chief medical officer, Freenome. “This collaboration is an important step in advancing early cancer detection.” 

The Sanderson Study will enroll approximately 8,000 participants through its clinical study partner network, which includes Walgreens. For more information, visit sanderson.freenome.com. 

Clinical trials inclusive of diverse communities are critical to improving health outcomes, especially in cancer research. The collaboration between Walgreens and Freenome aligns with the National Cancer Plan’s goals of detecting cancer early and eliminating inequities. Cancer claims nearly 2,000 lives daily in the United States, but proactive screening tests can help find cancer at an early stage even before symptoms appear1. Additionally, Black individuals of all ages have higher mortality rates than any other racial or ethnic groups for many cancer types2. 

Walgreens and Freenome will also work together on building risk-prediction models and population health software. The aim is to help close existing care gaps and identify people who are eligible and stand to benefit from standard-of-care cancer detection testing. Real-world data collected by Walgreens as part of this collaboration will inform the development of new products and services in Freenome’s multi-cancer detection research, including the company’s blood-based colorectal cancer screening test. 

Since launching in June 2022, Walgreens clinical trials business has directly addressed industrywide access, experience and diversity challenges via its three service lines focused on patient recruitment, decentralized clinical trials and real-world evidence. Built on a fully compliant regulatory framework, the central focus of the Walgreens clinical trials experience remains patient choice. Walgreens recently achieved a milestone of conducting outreach to its 1 millionth patient for potential participation in the ongoing trials it supports. 

About Walgreens 
Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader with a 170-year heritage of caring for communities. WBA’s purpose is to create more joyful lives through better health. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation’s underserved populations. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide. 

About Freenome 
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. 
 

1 National Cancer Institute: Cancer Screening Overview (PDQ®)–Patient Version. Source: https://www.cancer.gov/about-cancer/screening/patient-screening-overview-pdq#:~:text=Screening%20tests%20can%20help%20find,harder%20to%20treat%20or%20cure 

2 National Cancer Institute: Cancer Disparities. Source: https://www.cancer.gov/about-cancer/understanding/disparities

OVERLAND PARK, Kan., July 13, 2023 /3BL/ — As climate change presents increasing challenges and opportunities, global critical human infrastructure leader Black & Veatch has selected seven participants to take part in its 12-week IgniteX Climate Tech Accelerator program, which provides funding and support to companies on the cutting edge of climate technology.

The seven startups were selected from a pool of 118 applicants, a 38 percent increase in applicants from 2022. The included startups specialize in areas such as AI technology, carbon capture and reduction, and sustainable nutrition.

“Our commitment to developing infrastructure that combats the effects of climate change doesn’t end with Black & Veatch’s projects but extends as we simultaneously work to partner with and empower emerging startup companies in their efforts to create the next breakthrough in decarbonization and sustainability,” said Ryan Pletka, vice president of innovation for Black & Veatch. “As our fourth cohort, this group of participants brings a diverse background of ideas and innovation that is crucial in climate technology.”

IgniteX empowers startups offering scalable climate solutions for critical infrastructure. The seven selected program participants will partner with Black & Veatch subject matter leaders to co-develop, pilot and market their new technologies. Along the way they will receive mentorship, access to the company’s vast industry network, product testing opportunities, pitch development coaching and investor introductions.

The seven 2023 IgniteX Climate Tech Accelerator program participants are as follows:

EarthEn enables grid resiliency with their novel thermo-mechanical solutions, using CO2 in a closed loop to store energy in a cost-effective manner.CarbonQuest is elevating standard carbon capture and sequestration solutions for commercial, residential, and smaller industrial buildings.Mars Materials replaces petroleum by sequestering CO2 into everyday products such as carbon fiber and wastewater treatment chemicals.Strive is a sustainable nutrition company using precision fermentation to create protein-enriched, animal-free milk and other beverages.Spira uses genetically engineered algae to replace harmful petrochemicals and reinvent the basic materials we use every day.Looq AI automates the creation of digital twins by capturing the complex physical world in detailed and intelligent 3D models.Simerse enhances GIS, asset inventory, and condition monitoring through visual data AI for utilities, telecommunications, and cities.

Contact Black & Veatch for more information.

Editor’s Notes: 

Black & Veatch’s IgniteX Climate Tech Accelerator was recently awarded a U.S. Department of Energy EPIC Prize as a finalist in the program for our high-impact ideas in energy innovation.The IgniteX Tech Accelerator program includes funding for each participating company of up to $35,000 in non-dilutive grants and in-kind services plus potential equity investments up to $50,000. Learn more about the IgniteX Climate Tech Accelerator program here.This is the fourth year of the program which has seen 40+ participants and funding of more than $1 million.

About Black & Veatch 
Black & Veatch is a 100-percent employee-owned global engineering, procurement, consulting and construction company with a more than 100-year track record of innovation in sustainable infrastructure. Since 1915, we have helped our clients improve the lives of people around the world by addressing the resilience and reliability of our most important infrastructure assets. Our revenues in 2022 were US$4.3 billion. Follow us on www.bv.com and on social media.

Media Contact Information:

MEGHAN LOCKNER | +1 201-977-1628 | locknerm@bv.com 
24-HOUR MEDIA CONTACT | Media@bv.com